Bristol-Myers Squibb
BMY
#189
Rank
A$165.58 B
Marketcap
A$81.34
Share price
-0.13%
Change (1 day)
-9.10%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): A$4.61

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$4.42. In 2024 the company made an earnings per share (EPS) of A-$6.58 a decrease over its 2023 EPS that were of A$5.78.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$4.61-170.06%
2024A-$6.58-213.92%
2023A$5.7830.2%
2022A$4.44-6.04%
2021A$4.72-179.29%
2020A-$5.95-281.37%
2019A$3.28-27.21%
2018A$4.51
2016A$3.97175.26%
2015A$1.44-19.83%
2014A$1.80-22.44%
2013A$2.3234.48%
2012A$1.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$2.56-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.30 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$30.54 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.96 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$5.52 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
A$4.52 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$15.54 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.01-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$19.40 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$16.36 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA